首页> 外国专利> Use of Human chorionic gonadotropin orally or by injection in the treatment of metabolic syndrome

Use of Human chorionic gonadotropin orally or by injection in the treatment of metabolic syndrome

机译:口服或注射人绒毛膜促性腺激素用于治疗代谢综合征

摘要

The metabolic syndrome (MS), also known as plurimetabolico Syndrome, insulin resistance Syndrome or Syndrome X is a Clinical entity that appears with large phenotypic variations in People with a predisposition to endogenous, genetically determined and conditioned by FA Ctores Environmental.Is the use of Human chorionic gonadotropin by oral or Injection for the treatment of metabolic syndrome and is intended for the treatment of patients with picture of one or several of the following clinical signs or laboratory analysis: hypertension, diabetes Type 2, reactive hyperglycemia, high levels of plasma triglyceride, cholesterol levels are high,When the gouty disease with metabolic syndrome.
机译:代谢综合症(MS)也称为多代谢综合征,胰岛素抵抗综合症或X综合征是一种临床个体,在具有内源性,易受FA Ctores Environmental遗传和条件影响的人群中表现出较大的表型变异。人绒毛膜促性腺激素通过口服或注射治疗代谢综合征,旨在治疗具有以下一种或几种以下临床症状或实验室分析结果的患者:高血压,2型糖尿病,反应性高血糖,血浆甘油三酯水平高,胆固醇水平高,当痛风病伴有代谢综合征。

著录项

  • 公开/公告号AR061280A1

    专利类型

  • 公开/公告日2008-08-20

    原文格式PDF

  • 申请/专利权人 BELLUSCIO DANIEL OSCAR;

    申请/专利号AR2007P105510

  • 发明设计人 BELLUSCIO DANIEL OSCAR;

    申请日2007-12-07

  • 分类号A61K38/24;A61P3/00;

  • 国家 AR

  • 入库时间 2022-08-21 20:08:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号